Novel biodegradable functional amino acid-based poly(ester amide) biomaterials: Design, synthesis, property and biomedical applications

Journal of Fiber Bioengineering and Informatics

Volumn 5, Issue 1, 2012, Pages 1-31

  Chu, C C ^a  

^a Cornell University ^*  (United States)

Author keywords

Amino Acids; Biodegradable; Biomaterials; Biomedical Applications; Electrospinning; Fibers; Fibrous Membrane; Hydrogels; Inflammation; Microspheres; Poly(ester amide); Synthesis

Indexed keywords

EID: 84864485985     PISSN: 19408676     EISSN: None     Source Type: Journal    
DOI: 10.3993/jfbi03201201     Document Type: Article

References (117)

1. Chu CC, von Fraunhofer JA, and Greisler HP. Wound Closure Biomaterials and Devices. Boca Raton, Fla: CRC Press, 1997.
2. Chu CC, An overview of surgical suture biomaterials. In: King M, and Gupta BS, editors. Biotextiles as Medical Implants. Cambridge, England: Woodhead Publishing, In Press.
3. Pillai CKS and Chandra P. Sharma. Absorbable polymeric surgical sutures: Chemistry production, properties, biodegradability, and performance. J Biomater Appl 2010; 25: 291-366.
4. Uhrich KE, Cannizzaro SM, Langer RS, Shakeshe KM. Polymeric Systems for Controlled Drug Release. Chemical Reviews (Washington, D C) 1999; 99(11): 3181-3198.
5. Langer R. New methods of drug delivery. Science (New York, NY) 1990; 249(4976): 1527-1533.
6. Barrera DA, Zylstra E, Lansbury PT, Jr., Langer R. Synthesis and RGD peptide modi-cation of a new biodegradable copolymer: poly(lactic acid-co-lysine). J of the Am Chem Soc 1993; 115(23): 11010-11011.
7. Barrera DA, Zylstra E, Lansbury PT, Langer R. Copolymerization and degradation of poly(lactic acid-co-lysine). Macromolecules 1995; 28(2): 425-432.
8. Langer R, Tirrell DA. Designing materials for biology and medicine. Nature (London, United Kingdom) 2004; 428(6982): 487-492.
9. Wang Y, Ameer GA, Sheppard BJ, Langer R. A tough biodegradable elastomer. Nature Biotechn 2002; 20(6): 602-606.
10. West JL. Drug delivery: Pulsed polymers. Nature Materials 2003; 2(11): 709-710.
11. Chu CC, and Katsarava R. Elastomeric functional biodegradable copolyester amides and copolyester urethanes, US Patent No. 6,503,538, 2003.
12. Katsarava R, Beridze V, Arabuli N, Kharadze D, Chu CC, and Won CY. Amino acid based bioanalogous polymers. Synthesis and study of regular poly (ester amide)s based on bis(a-amino acid) α, omeg;-alkylene diesters and aliphatic dicarboxylic acids. J. Polym. Sci., Polymer Chemistry Ed. 1999; 37: 391-407.
13. Paredes, N, Casas MT. Puiggali J. Packing of sequential poly(ester amide)s derived from diols, dicarboxylic acids, and amino acids. Macromolecules 2000; 33: 9090-9097.
14. Barrows, TH. Degradable implant materials: A review of synthetic absorbable polymers and their applications. Clin. Mater. 1986; 1: 233-257.
15. Bettinger CJ, Bruggeman JP, Borenstein JT, Langer RS. Amino alcohol-based degradable poly(ester amide) elastomers. Biomaterials 2008; 29: 2315-2325.
16. Garg P, Keul H, Klee D, Moeller M. Thermal properties of poly(ester amide)s with isolated, two adjacent and three adjacent amide groups within a polyester chain. Macromol. Chem. Phys. 2009; 210: 1754-1765.
17. Kim, TH, Cook SE, Arote RB, Cho MH, Nah J W, Choi YJ, Cho CS. A degradable hyperbranched poly(ester amine) based on poloxamer diacrylate and polyethylenimine as a gene carrier. Macromol. Biosci. 2007; 7: 611-61.
18. Paredes N, Rodriguez-Galan A, Puiggali J. Synthesis and characterization of a family of biodegradable poly(ester amide)s derived from glycine. J. Polym. Sci. Part A: Polym. Chem. 1998; 36: 1271-1282.
19. Asin L, Armelin E, Montane J, Rodriguez-Galan A, Puiggali J. Sequential poly(ester amide)s based on glycine, diols, and dicarboxylic acids: Thermal polyesteri-cation versus interfacial polyamidation: Characterization of polymers containing stiff units. J. Polym. Sci. Part A: Polym. Chem. 2001; 39: 4283-4293.
20. Han SI, Kim BS, Kang SW, Shirai H, Im SS. Cellular interactions and degradation of aliphatic poly(ester amide)s derived from glycine and/or 4-amino butyric acid. Biomaterials 2003; 24: 3453-3462.
21. Guo K, Chu CC. Copolymers of unsaturated and saturated poly(ether ester amide)s: Synthesis, characterization, and biodegradation. J. Appl. Polym. Sci. 2008; 110: 1858-1869.
22. Guo K, Chu CC. Controlled release of paclitaxel from biodegradable unsaturated poly(ester amide)s/poly(ethylene glycol) diacrylate hydrogels. J. Biomater. Sci. Polym. Ed. 2007; 18: 489-504.
23. Chkhaidze E, Tugushi D, Kharadze D, Gomurashvili Z, Chu CC, Katsarava R. New unsaturated biodegradable poly(ester amide)s composed of fumaric acid, L-leucine and α, omeg;-alkylene diols. J. Macromol. Sci. Part A 2011: 48: 544-555.
24. Wu, J, Mutschler MA, Chu CC. Synthesis and characterization of ionic charged water soluble arginine-based poly (ester amide). J. Mater. Sci. Mater in Med. 2011: 22: 469-479.
25. Jokhadze G, Machaidze M, Panosyan H, Chu CC, Katsarava R. Synthesis and characterization of functional elastomeric poly(ester amide) co-polymers. J. Biomater. Sci. Polymer Edn. 2007: 18: 411-438.
26. Guo K, Chu CC. Synthesis characterization and biodegradation of novel poly(ether ester amide)s based on L-phenylalanine and oligoethylene glycol. Biomacromolecules 2007; 8: 2851-2861.
27. Tsitlanadze G, Machaidze M, Kviria T, Djavakhishvili N, Chu CC, Katsarava R. Biodegradation of amino-acid-based poly(ester amide)s: In vitro weight loss and preliminary in vivo Studies. J. Biomater. Sci. Polym. Ed. 2004; 15: 1-24.
28. Li L, Chu CC. Nitroxyl radical incorporated electrospun biodegradable poly(ester amide) nano-ber membranes J. Biomater. Sci. Polym. Ed. 2009; 20: 341-361.
29. Guo K, Chu CC. Biodegradation of unsaturated poly(ester amide)s and their hydrogels. Biomaterials 2007; 28: 3284-3294.
30. Katsarava R. Active polycondensation: From peptide chemistry to amino acid based biodegradable polymers. Macromol. Symp. 2003; 199: 419-429.
31. Fan YJ, Kobayashi M, Kise H. Synthesis and speci-c biodegradation of novel polyester amides containing amino acid residues. J. Polym. Sci., Part A: Polym. Chem. 2001; 39: 1318-1328.
32. Horwitz JA, Shum KM, Bodle JC, Deng MX, Chu CC, Reinhart-King CA. Biological performance of biodegradable amino acid-based poly(ester amide)s: Endothelial cell adhesion and inflammation in vitro. J. Biomed. Mater. Res. Part A, 2010; 95: 371-380.
33. Deng MX, Wu J, Reinhart-King CA, Chu CC. Biodegradable functional poly(ester amide)s with pendant hydroxyl functional groups: Synthesis, characterization, fabrication and in vitro cellular response. Acta Biomaterialia 2011; 7: 1504-1515.
34. Deng MX, Wu J, Reinhart-King CA, Chu CC. Synthesis and characterization of biodegradable poly(ester amide)s with pendant amine functional groups and in vitro cellular response. Biomacromolecules 2009; 10: 3037-3047.
35. Pang X, Chu CC. Synthesis, characterization and biodegradation of novel poly(ester amide)s and their functionalization. Biomaterials 2010; 31: 3745-3754.
36. Pang X, Wu J, Reinhart-King C, and Chu CC. Synthesis and characterization of functionalized water soluble cationic poly(ester amide)s. J. Polym. Sci. Part A: Polym. Chem. 2010; 48: 3758-3766.
37. De Wit MA, Wang ZX, Atkins KM, Mequanint K, Gillies ER. Syntheses, characterization, and functionalization of poly(ester amide)s with pendant amine functional groups J. Polym. Sci. part A: Polym. Chem. 2008; 46: 6376-6392.
38. DeFife KM, Grako K, Cruz-Aranda G, Price S, Chantung R, Macpherson K, Khoshabeh R, Gopalan S, Turnell WG. Poly(ester amide) co-polymers promote blood and tissue compatibility. J. Biomater. Sci.-Polym. Ed. 2009; 20: 1495-1511.
39. Wu J. Arginine and Phenylalanine Based Poly(ester amide)s: Synthesis, Characterization and Applications. PhD thesis, Cornell University, Aug. 5, 2010.
40. Schwartz S, Demars S, Chu CC, White J, Cooper A, Rothrock M, Adelman M, Yurt R. Efficacy of poly(ester amide) dressings on partial thickness wound healing. A 3rd World Union of Wound Healing Societies. 2008, June 4-8, in Toronto, Canada.
41. Vera M, Almontassir A, Rodriguez-Galan, A.; Puiggali, J. Synthesis and characterization of a new degradable poly(ester amide) derived from 6-amino-1-hexanol and glutaric acid. Macromolecules 2003; 36: 9784-9796.
42. Botines E, Casas MT, Puiggali J. Alternating poly(ester amide)s of glycolic acid and omeg;-amino acids: Crystalline morphology and main crystallographic data. J. Polym. Sci. Part B: Polym. Phys. 2007; 45: 815-825.
43. Armelin E, Paracuellos N, Rodriguez-Galan A, Puiggali J. Study on the degradability of poly(ester amide)s derived from the α-amino acids glycine, and L-alanine containing a variable amide/ester ratio. Polymer, 2001; 42: 7923-7932.
44. Song H, Chu CC. Synthesis and characterization of a new family of cationic poly(ester amide)s and their biological properties. J. Appl. Polym. Sci. 2011.(In Press)
45. Rodriguez-Galan A, Pelfort M, Aceituno JE, Puiggali J. Comparative studies on the degradability of poly(ester amide)s derived from Land L,D-alanine. J. Appl. Polym. Sci. 1999; 74: 2312-2320.
46. Guo K, Chu CC. Synthesis of biodegradable amino acid-based poly(ester amide) and poly(ether ester amide) with pendant functional groups. J. Appl. Polym. Sci. 2010; 117: 3386-3394.
47. Yamanouchi D, Wu J, Lazar AN, Craig Kent K, Chu CC, Liu B. Biodegradable arginine-based poly(ester-amide)s as non-viral gene delivery reagents. Biomaterials 2008; 29(22): 3269-3277.
48. Song H. L-arginine-based biodegradable poly(ester amide)s, their synthesis, characterization, fabrication, and application as drug and gene carriers: 2007, PhD thesis, Cornell University: Ithaca, NY, USA.
49. Chu C, and Sun D. New electrospun synthetic biodegradable poly(ester amide) drug-elutingfibrous membranes for potential wound treatment. in Medical, Nonwovens, and Technical Textiles. 2008. Durham NC.
50. Guo K, and Chu CC. Biodegradable and injectable paclitaxel-loaded poly(ester amide)s microspheres: Fabrication and characterization. J Biomed Mater Res Part B-Applied Biomaterials, 2009; 89B(2): 491-500.
51. Pang X, and Chu C. Synthesis, characterization and biodegradation of poly(ester aminde)s based hydrogels. Polymer, 2010; 51: 4200-4210.
52. Guo K, and Chu CC. Controlled release of Paclitaxel from biodegradable unsaturated poly(ester amide)s/poly(ethynene glycol) diacrylate hydrogels. J Biomater Sci Polym Ed., 2007; 18(5): 489-504.
53. Guo K, Chu CC, Chkhaidze E, and Katsarava R. Synthesis and characterization of novel biodegradable unsaturated poly(ester-amide)s, J Polym Sci Polym Chem, 2005; 43: 1463-1477.
54. Lewis P, and Chu C. Novelfibrous scaffold for wound management, In: The Fiber Society 2004 Fall Symposium on Advanced Materials and Processes, Oct. 11-13, 2004, Cornell University, Ithaca, NY.
55. Anderson JM, Rodriguez A, and Chang DT. Foreign body reactions to biomaterials, Seminars in Immunology, 2008; 20: 86-100.
56. Whitaker MJ, Wuirk RA, Howdie SM, Shakeshe KM. Growth factor release from tissue engineering scaffold. J. Pharm. Pharmacol, 2001; 53(11): 1427-1437.
57. Lee SH, Szinai I, Carpenter K, Katsarava R, Jokhadze G, Chu CC, De Scheerder I, and Hong MK, In vivo biocompatibility evaluation of stents coated by a new biodegradable elastomeric and functional polymer. Coronary Artery Disease, 2002; 13(4): 237-241.
58. http://www.ameriburn.org/resources factsheet.
59. Petrie NC, Yao F, Eriksson E. Gene therapy in wound healing. Surg Clin N Am 2003; 83(3): 194-199.
60. Advanced Medical Technology Association. Advanced Wound Management: Healing and Restoring Lives. June 2006. www.advamed.org/NR/rdonlyres/8D8348E8-811D-48A9-873761D91060DDAD/0/june2006 woundmanagement.pdf
61. Samsom D, Lefevre F, Aronson N. Wound Healing Technologies: Low-Level Laser and Vacuum Assisted Closure. Summary, Evidence Report/Technology Assessment No. 111. (Prepared by the Blue Cross and Blue Shield Association Technology Evaluation Center Evidence-based Practice Cener, under Contract No. 29002-0026). AHRQ Publication No. 05-E005-1. Rockville, MD: Agency for Healthcare Research and Quality. December2004.
62. Atiyeh BS, Hayek SN, Gunn SW. New technologies for burn wound closure and healing{Review of the literature. Burns 2005; 31: 944-956.
63. The Joanna Briggs Institute. Split Skin Graft Donor Sites: Post Harvest Management. Best Practice 2002; 6(2): 1-6.
64. Ehrenreich M, Ruszczak Z. Update on tissue-engineered biological dressings. Tissue Engineering 2006; 12(9): 2407-24.
65. Zilla P and Greisler HP. Tissue engineering of vascular prosthetic grafts. Austin, TX, R.G. Landes, Co., 1999.
66. Chu CC and Liu B. Novel biodegradable scaffold for tissue engineering of blood vessels, Annual Report to the Morgan Tissue Engineering Program, Jan. 28, 2008, Cornell University, Ithaca, New York.
67. Lindsay J Jr, Hong MK, Pinnow E, Pichard AD. Effects of intraluminal coronary stents on the frequency of coronary artery bypass grafting after unsuccessful percutaneous transluminal coronary revascularization. Am J Cardiol 1996; 77: 647-649.
68. Fischman DL, Leon MB, Baim DS, Schatz RA, Savage MP, Penn I, et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 1994; 331: 496-501.
69. Serruys PW, de Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 1994; 331: 489-495.
70. Kobayashi Y, De Gregorio J, Kobayashi N, Akiyama T, Reimers B, Finci L, et al. Stented segment length as an independent predictor of restenosis. J Am Coll Cardiol 1999; 34: 651-659.
71. Akiyama T, Moussa I, Reimers B, Ferraro M, Kobayashi Y, Blengino S, et al. Angiographic and clinical outcome following coronary stenting of small vessels. A comparison with coronary stenting of large vessels. J Am Coll Cardiol 1998; 32: 1610-1618.
72. Abizaid A, Kornowski R, Mintz GS, Hong MK, Abizaid AS, Mehran R, et al. The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation. J Am Coll Cardiol 1998; 32: 584-589.
73. Cutlip DE, Baim DS, Ho KK, Popma JJ, Lansky AJ, Cohen DJ, et al. Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials. Circulation 2001; 103: 1967-1971.
74. Colombo A, Hall P, Nakamura S, Almagor Y, Maiello L, Martini G, et al. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation 1995; 91: 1676-1688.
75. Leon MB, Baim DS, Popma JJ, Gordon PC, Cutlip DE, Ho KK, et al. A clinical trial comparing three antithrombotic-drug regimens after coronary artery stenting. N Engl J Med 1998; 339: 1665-1671.
76. Hardhammar PA, van Beusekom HM, Emanuelsson HU, Hofma SH, Albertsson PA, Verdouw PD, et al. Reduction in thrombotic events with heparin-coated Palmaz{Schatz stents in normal porcine coronary arteries. Circulation 1996; 93: 423-430.
77. Serruys PW, Emanuelsson H, van der Giessen W, Lunn AC, Kiemeney F, Macaya C, et al. Heparincoated Palmaz{Schatz stents in human coronary arteries: early outcome of the BENESTENT-II pilot study. Circulation 1996; 93: 412-422.
78. Schwartz RS, Huber KC, Murphy JG, Edwards WD, Camrud AR, Vlietstra RE, et al. Restenosis and the proportional neointimal response to coronary artery injury: results in a porcine model. J Am Coll Cardiol 1992; 20: 467-474.
79. Mintz GS, Popma JJ, Pichard AD, Kent KM, Satler LF, Wong SC, et al. Arterial remodeling after coronary angioplasty: a serial intravascular ultrasound study. Circulation 1996; 94: 35-43.
80. Fajadet J, Perin M, Hayashi EB, Colombo A, Schuler G, Barragan P, et al. 210-day follow-up of the RAVEL study: a randomized study with the sirolimus-eluting BX VELOCITY balloon expandable stent in the treatment of patients with de novo native coronary artery lesions [abstract]. J Am Coll Cardiol 2002; 39(suppl A): 20A.
81. Park SJ, Shim WH, Ho DS, Raizner A, Park SW, Kim JJ, et al. The clinical effectiveness of paclitaxel-coated coronary stents for the reduction of restenosis in the ASPECT trial [abstract]. Circulation 2001; 104(Suppl II): II-464.
82. Chu CC, Lee KH, and Freed J. Aminoxyl-containing radical spin labeling in polymers and copolymers, U.S. Patent No. 5, 516, 881, 1996.
83. Lee KH & Chu CC. Molecular design of biologically active biodegradable polymers for biomedical applications, Macromol. Symposium (Huthig & Wepf Verlag, Zug) 1998; 130: 71-80.
84. van der Giessen WJ, Linco AM, Schwartz RS, van Beusekom HMM, Serruys PW, Holmes DR Jr, et al. Marked inflammatory sequelae to implantation of biodegradable and non-biodegradable polymers in porcine coronary arteries. Circulation 1996; 94: 1690-1697.
85. Linco AM, Furst JG, Ellis SG, Tuch RJ, Topol EJ. Sustained local delivery of dexamethasone by a novel intravascular eluting stent to prevent restenosis in the porcine coronary injury model. J Am Coll Cardiol 1997; 29: 808-816.
86. Hong MK, Kornowski R, Bramwell O, Ragheb AO, Leon MB. Paclitaxel-coated Gianturco{Roubins stents reduce neointimal hyperplasia in a porcine coronary in-stent restenosis model. Coron Artery Dis 2001; 12: 513-515.
87. Costantini CR, Londero H, DeScheeder I, Tarbine SG, Costantini CO, Cabrera MJ, Santos MF, Darwich RZ, Maranhao MC, Bubna M, Andrade MS, Yared A. Final results and two year outcomes of a trial assessing a nitric oxide preserver polymer-coated stent implantation in De Novo Coronary lesions: Clinical, angiographic, and stent volumetric analysis from NOBLESSE trial. Am. J. Cardiol. 2005; 96 (suppl 7A): 39H.
88. Gaillard BD. Sheathed surgical suture lament and method for its preparation, U.S. Patent No. 4, 506, 672, 1985.
89. Mulligan RC. The Basic Science of Gene-Therapy. Science (New York, N.Y.) 1993; 260 (5110): 926-932.
90. Pack DW, Hoffman AS, Pun S, Stayton PS. Design and development of polymers for gene delivery. Nature Reviews Drug Discovery 2005; 4 (7): 581-593.
91. Wol JA, Lederberg J., An early history of gene-transfer and therapy. Human Gene Therapy 1994; 5(4): 469-480.
92. Wol JA, Trubetskoy VS. The Cambrian period of nonviral gene delivery. Nature Biotechnology 1998; 16(5): 421-422.
93. Lynn DM, Anderson DG, Putnam D, Langer R. Accelerated discovery of synthetic transfection vectors: Parallel synthesis and screening of degradable polymer library. J of the Am Chem Soc 2001; 123(33): 8155-8156.
94. Mahato RI, Smith LC, Rolland A. Pharmaceutical perspectives of nonviral gene therapy. In: Hall J, Dunlap J, Friedmann, T, Giannelli F, editors. Advances in Genetics, New York: Academic Press, 1999. Vol. 41, pp 95-156.
95. Putnam D, Polymers for gene delivery across length scales. Nature Materials 2006; 5(6): 439-451.
96. Putnam D, Gentry CA, Pack DW, Langer R. Polymer-based gene delivery with low cytotoxicity by a unique balance of side-chain termini. Proceedings of the National Academy of Sciences of the United States of America 2001, 98, (3), 1200-1220.
97. Luo D, Saltzman WM. Synthetic DNA delivery systems. Nature biotechnology 2000: 18(1): 33-37.
98. Boussif O, Lezoualc'h F, Zanta MA, Mergny MD, Scherman D, Demeneix B, Behr JP. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci U S A 1995; 92(16): 7297-301.
99. Verma IM, Somia N. Gene therapy promises, problems and prospects. Nature 1997; 389 (6648): 239-242.
100. Zauner W, Ogris M, Wagner E. Polylysine-based transfection systems utilizing receptor-mediated delivery. Advanced Drug Delivery Reviews 1998; 30(1-3): 97-113.
101. Katayose S, Kataoka K. Water-Soluble Polyion Complex Associates of DNA and Poly(ethylene glycol)-Poly(L-lysine) Block Copolymer. Bioconjugate Chemistry 1997; 8(5): 702-707.
102. Wagner E, Zatloukal K, Cotten M, Kirlappos H, Mechtler K, Curiel DT, Birnstiel ML. Coupling of adenovirus to transferrin-polylysine/DNA complexes greatly enhances receptor-mediated gene delivery and expression of transfected genes. Proceedings of the National Academy of Sciences of the United States of America 1992; 89(13): 6099-103.
103. Zhong Z, Feijen J, Lok MC, Hennink WE, Christensen LV, Yockman JW, Kim YH, Kim SW. Low molecular weight linear polyethylenimine-b-poly(ethylene glycol)-b-polyethylenimine triblock copolymers: synthesis, characterization, and in vitro gene transfer properties. Biomacromolecules 2005; 6(6): 3440-3448.
104. Pollard H, Remy JS, Loussouarn G, Demolombe S, Behr JP, Escande D. Polyethylenimine but not cationic lipids promotes transgene delivery to the nucleus in mammalian cells. J of Biol Chem 1998; 273(13): 7507-7511.
105. Liu X, Yang JW, Lynn DM. Addition of \charge-shifting side chains to linear poly(ethyleneimine) enhances cell transfection efficiency. Biomacromolecules 2008; 9(7): 2063-2071.
106. Tekade RK, Kumar PV, Jain NK. Dendrimers in Oncology: An expanding horizon. Chemical Reviews (Washington, DC, United States) 2009; 109(1): 49-87.
107. Tomalia DA, Naylor AM, Goddard WA. Starburst Dendrimers Molecular-Level Control of Size, Shape, Surface-Chemistry, Topology, and Flexibility from Atoms to Macroscopic Matter. Angewandte Chemie-International Edition in English 1990; 29(2): 138-175.
108. Wong K, Sun G, Zhang X, Dai H, Liu Y, He C, Leong KW. PEI-g-chitosan, a novel gene delivery system with transfection efficiency comparable to polyethylenimine in vitro and after liver administration in vivo. Bioconjugate Chemistry 2006; 17(1): 152-158.
109. Koeping-Hoeggard M, Varum KM, Issa M, Danielsen S, Christensen BE, Stokke BT, Artursson P. Improved chitosan-mediated gene delivery based on easily dissociated chitosan polyplexes of highly de-ned chitosan oligomers. Gene Therapy 2004; 11(19): 1441-1452.
110. Wu J, Wang X, Keum JK, Zhou H, Gelfer M, Avila-Orta CA, Pan H, Chen W, Chiao SM, Hsiao BS, Chu B. Water soluble complexes of chitosan-g-MPEG and hyaluronic acid. J of Biomed Mater Res, Part A 2007; 80A(4): 800-812.
111. Ihm JE, Han KO, Han IK, Ahn KD, Han DK, Cho CS. High transfection efficiency of poly(4vinylimidazole) as a new gene carrier. Bioconjugate Chemistry 2003; 14(4): 707-708.
112. Midoux P, Monsigny M. Efficient gene transfer by histidylated polylysine pDNA complexes. Bioconjugate Chemistry 1999; 10(3): 406-411.
113. Pack DW, Putnam D, Langer R. Design of imidazole-containing endosomolytic biopolymers for gene delivery. Biotechnology and Bioengineering 2000; 67(2): 217-223.
114. Thomas JL, Tirrell DA. Polyelectrolyte-sensitized phospholipid-vesicles. Accounts of Chemical Research 1992; 25(8): 336-342.
115. Thomas JL, Barton SW, Tirrell DA. Membrane solubilization by a hydrophobic polyelectrolyte surface-activity and membrane-binding. Biophysical J 1994; 67(3): 1101-1106.
116. Lim YB, Kim CH, Kim K, Kim SW, Park JS. Development of a safe gene delivery system using biodegradable polymer, poly [alpha-(4-aminobutyl)-L-glycolic acid]. J of the Am Chem Soc 2000; 122(27): 6524-6525.
117. Lynn DM, Langer R. Degradable poly(beta-amino esters): Synthesis, characterization, and selfassembly with plasmid DNA. J Am Chem Soc 2000; 122(44): 10761-10768.